Naprelan '500' Information
What's inside Naprelan '500'
Naprelan '500' Active Ingredients: naproxen sodium, details.| Naprelan '500' Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Naprelan '500' sodium 550 mg | tablet, extended release | oral | 1.0 each | OTC |
Naprelan '500' in the News
Santarus Reports Third Quarter 2007 Financial Results - PharmaLive.com (press release)
Santarus(R) and ZEGERID(R) are trademarks of Santarus, Inc. Naprelan(R) is a registered trademark of Elan Corporation, plc. Fleet(R) is a trademark of CB ...
Fri Nov 02 08:33:04 -0400 2007
Santarus Reports Third Quarter 2007 Financial Results - WELT ONLINE
Santarus® and ZEGERID® are trademarks of Santarus, Inc. Naprelan® is a registered trademark of Elan Corporation, plc. Fleet® is a trademark of CB Fleet ...
Thu Nov 01 13:29:35 -0400 2007
Victory Pharma, Inc. Doubling US Sales Force - Earthtimes.org
NAPRELAN (naproxen sodium) Controlled Release Tablets are commercially available in 375 mg and 500 mg dosage strengths. NAPRELAN Tablets use Elan's ...
Tue Jul 10 05:15:22 -0400 2007
Naprelan '500' Chemical Information
naproxen sodium - The sodium salt form of naproxen, a member of the arylacetic acid group of non-steroidal anti-inflammatory drugs (NSAIDs) with anti-inflammatory analgesic and antipyretic properties. Naproxen sodium reversibly and competitively inhibits cyclooxygenases (COX), thereby blocking the conversion of arachidonic acid to pro-inflammatory prostaglandins. This inhibits the formation of prostaglandins that are involved in pain, inflammation and fever.
Naprelan '500' RSS Feed